Penn Gaming PENN stock analysis

FDA rejects liver cancer drug combo, shares of Korean biotech tank

Korean biotech HLB and its China-based partner Jiangsu Hengrui Pharmaceuticals said Friday that the FDA rejected their drug combination for the most common form of

May 18, 2024

TILT Holdings Q1 Revenue Falls 5% From Q4

TILT Holdings Reports First Quarter 2023 Results PHOENIX, May 15, 2023 (GLOBE NEWSWIRE) — TILT Holdings Inc. (“TILT” or the “Company”) (NEO: TILT) (OTCQX: TLLTF),

May 16, 2023

Vivet wins $5.3m grant to develop gene therapy for rare metabolic disorder – Pharmaceutical Technology

Share this article Vivet’s VTX-806 is an adeno-associated virus (AAV) vector gene therapy that reinstates CYP27A1 gene activity. Image Credit: Anusorn Nakdee / Shutterstock. The French

February 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.